. Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading. Acta Radiol 2008;49:450Á457.
The degree of angiogenesis is a key determinant of the malignant potential of a brain tumor. Tumor angiogenesis is a pathophysiologic process that has been linked to tumor viability and tumor grade (1, 2) . Therefore, antiangiogenic treatment strategies have proliferated during the past decade (3, 4) .
Although conventional MR imaging with gadolinium contrast is useful for the detection and structural characterization of brain tumors, enhancement after gadolinium reflects disruption of the bloodÁbrain barrier rather than a true assessment of tumor vascularity (5) . The recent development of MR perfusion imaging has made it possible to assess cerebral perfusion (1, 6) . Dynamic susceptibility contrast (DSC) perfusion imaging has the potential to provide noninvasive assessment of tumoral vascularity that is not available on conventional MR imaging (7) . Comparisons of relative cerebral blood volume (rCBV) with histologic sections in patients with glioma have demonstrated a significant correlation between tumor vascularity and maximum tumor rCBV (8) . Moreover, in a recent study, rCBV measurements have been used to assess tumor activity during antiangiogenic therapy (9) .
The arterial spin labeling (ASL) MR perfusion technique allows cerebral blood flow (CBF) to be measured noninvasively without the use of exogenous contrast agents. This perfusion technique uses water protons in arterial blood as an endogenous contrast agent, making it a perfectly safe imaging modality (10, 11) . An important practical advantage of the ASL technique is the ease of quantification without extensive postprocessing. Perfusion data can be obtained in a flexible manner (e.g., without the necessity to prepare a power injector) and can be integrated into a conventional MR imaging examination at any time as long as no contrast agent has been administered. However, ASL imaging shows lower signal-to-noise ratio than DSC perfusion imaging. Therefore, the interobserver variability of results of ASL MR imaging must be established in a more clinically realistic setting before the technique can find more widespread use (12) .
The purpose of this study was to assess the diagnostic accuracy and interobserver variability of tumor perfusion measurements using the pulsed ASL (PASL) technique in glioma grading during routine brain tumor imaging.
Material and Methods

Patients
This study was approved by our institutional review board, and prior informed consent was obtained from all patients or from members of their families before entering them into this study. Between May 2005 and August 2007, 82 consecutive patients with suspected gliomas detected on conventional MR images were examined. All patients underwent both PASL and conventional MR imaging before surgery (n062) or stereotactic biopsy (n 020). Only diffuse astrocytomas were included. Ultimately, 61 astrocytomas were proven pathologically in 58 patients. There were 32 males and 26 females, with an age ranging between 19 and 74 years, and a mean 43 years.
An experienced neuropathologist performed the histopathologic evaluation, which was based on a revised World Health Organization (WHO) brain tumor classification of gliomas (13) : grade II, lowgrade glioma; grade III, anaplastic glioma; and grade IV, glioblastoma multiforme. The imaging classification was divided into two tiers. Anaplastic astrocytomas and glioblastoma multiforme were considered as high-grade gliomas, and this group comprised 35 tumors. The low-grade astrocytomas group comprised 26 tumors.
MR imaging protocol
Conventional MR imaging. MR imaging was performed using a 1.5T system (Signa Excite; GE Medical Systems, Milwaukee, Wisc., USA) and included the following sequences: axial fast spin-echo T2-weighted imaging (TR/TE 4000/120 ms), axial spin-echo T1-weighted imaging (TR/TE 400/9 ms), fluid-attenuated inversion recovery (FLAIR) imaging (TR/TE 8500/130 ms), and contrast-enhanced axial and coronal T1-weighted imaging. For acquiring all the MR images, an eight-channel head coil was used for radiofrequency transmission and signal reception. The contrast-enhanced axial and coronal T1-weighted sequences were performed after administering 0.1 mmol gadodiamide per kg body weight.
Pulsed arterial spin labeling imaging. The PASL perfusion MR imaging was performed using a multislice flow-sensitive alternating inversion recovery (FAIR) technique. The FAIR sequence comprised alternating slice-selective and nonselective radiofrequency inversion pulses, and was performed using an inversion time (TI) of 1200 ms between labeling and image acquisition. The TI was chosen based on the T1 decay of the magnetically labeled water proton. The final FAIR perfusion maps were obtained by subtracting the non-slice-selective inversion recovery images from the slice-selective images. The other imaging parameters used to perform the multislice FAIR technique were as follows: TR/TE 2000 ms/15 ms, field of view (FOV) 24 cm, matrix size 128)128, number of excitations 100, slice thickness 5 mm, slice number 7, slice gap 2 mm. Total acquisition time for multislice FAIR was 3 min 26 s. The subtracted images of CBF were transferred to a workstation (Advantage Workstation 4.1; GE Medical Systems, Milwaukee, Wisc., USA) for quantitative analysis, and additional postprocessing for the CBF map was not required.
DSC MR perfusion imaging. DSC MR images were performed in 10 study patients for comparison of time of acquisition and postprocessing with that of PASL images. DSC MR images were performed with gradient-echo echo-planar sequences during the injection of 0.2 mmol/kg body weight gadopentetate dimeglumine (Magnevist; Bayer Schering Pharma, Berlin, Germany) at a rate of 4 ml/s with an MR-compatible power injector (Spectris; Medrad, Pittsburgh, Pa., USA). The bolus of contrast material was followed by a 15-ml bolus of saline that was administered at the same injection rate. A gradient-echo echo-planar sequence was used with the following conditions: TR/TE 1600/ 80 ms, flip angle 908, FOV 24 cm, matrix 128)128, slice thickness 5 mm, number of slices 7, slice gap 2 mm. Total acquisition time for DSC MR imaging was 1 min 45 s. All imaging data were transferred from the scanners to an independent PC for quantitative analysis. Analysis was carried out with software written in house by using IDL (Interactive Data Language; Research Systems, Boulder, Colo., USA). A gamma-variate fit was used to derive hemodynamic parameters from the DSC MR image to obtain a map of relative CBF, relative CBV, and TTP in arbitrary units. After eliminating the recirculation of contrast agent with gamma-variate curve fitting, the relative CBV was computed by means of a numeric integration of the curve. The shape of the arterial input function was determined from the proximal middle cerebral artery, and the relative CBF was determined as the height of the deconvoluted tissue curve.
Image analysis
To compare the diagnostic accuracy of conventional imaging with or without adjunctive PASL, each observer reviewed the MR images of the 61 gliomas twice. In one review, the observers were given the conventional MR images only (conventional images only). In the other review, the observers were given the conventional MR images and PASL. Each observer participated in two review sessions, which were spaced 4 weeks apart to avoid recall bias. In the first review, two experienced board-certified neuroradiologists, blinded to the clinical information and PASL findings, reviewed the conventional MR images and graded each tumor according to the two-tier imaging grading system: low-versus high-grade gliomas. A consensus was reached on the conventional grading of each lesion based on eight criteria: contrast material enhancement, border definition, mass effect, signal intensity heterogeneity, hemorrhage, necrosis, degree of edema, and involvement of the corpus callosum or crossing the midline (14, 15) . Final pathologic diagnosis of the lesion was performed with the same categories. The radiologic grading of the gliomas was correlated with the pathologic grading.
In the second review, each observer picked a minimum of four regions of interest (ROIs) where he believed high tumor perfusion signal intensity (TPS) would be found. If the tumors were heterogeneous and these four TPS values were inconsistent, the observers were advised to pick one or two more ROIs, for a total of five or six ROIs. The highest of the TPS values found in these four to six ROIs were recorded (Fig. 1) . This method has been demonstrated to provide the most optimal interobserver and intraobserver reproducibility (16) . In the cases where there was no apparent increased TPS, which can often occur with lower-grade tumors, the ROI encompassed areas of enhancement apparent on the postcontrast T1-weighted images. The ROI did not include areas of necrosis or nontumor macrovessels evident on postcontrast T1-weighted images. In patients with weakly enhancing or non-enhancing tumors, the ROIs were chosen after identifying the tumor area as an area of hyperintensity on T2-weighted or FLAIR images (Fig. 1) . Cystic components were differentiated as Fig. 1 . MR images of a 74-year-old woman with anaplastic astrocytoma. Axial T2-weighted image (A) shows a mass of high signal intensity in the right frontal lobe, and this mass is not enhanced on contrast-enhanced T1-weighted image (arrow) (B). For the quantification analysis, four regions of interest were placed in the area of visually maximum tumor perfusion signal intensity on the pulsed arterial spin labeling image (arrow) (C). both areas of hyperintensity on T2-weighted MR images and areas of hypointensity on FLAIR MR images. Necrotic components were differentiated on contrast-enhanced T1-weighted images as the interior of enhanced lesions. Hemorrhagic lesions were differentiated on unenhanced T1-weighted MR images as areas of hyperintensity. The standardized ROI, which measured approximately 20Á25 mm 2 , was used in most measurements. TPS measurements are made relative to the contralateral normalappearing white matter, which acts as a standard internal reference. As a result, TPS measurements become a relative measure and are called relative TPS (rTPS). To assess the level of interobserver variability, the rTPS measurements were obtained independently by two neuroradiologists experienced with perfusion data acquisition. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of rTPS values for determining high-and low-grade gliomas were calculated using the averaged values between the two observers.
Statistical analysis
The sensitivity, specificity, PPV, and NPV were calculated for the correct identification of highgrade and low-grade gliomas. The sensitivity and specificity, with the 95% confidence limits, were estimated using standard statistical formulas, and were based on the consensus data from the quantitative measures. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of PASL that declared a glioma to be high or low grade if, and only if, the quantitative parameters for that suspected tumor were greater than or equal to some threshold value. This permitted the determination of the sensitivity, specificity, PPV, and NPV associated with each parameter as a function of the threshold value used to identify high-and low-grade gliomas. The ROC curve was analyzed using the MedCalc statistical package (MedCalc Software, Mariakerke, Belgium). The independent t test was used to compare histologically verified low-and high-grade gliomas in terms of rTPS. Spearman's correlation coefficient was used to correlate between rTPS values and glioma grade. All P values were two tailed with a level of 0.05 as the criterion for statistical significance. The Cohen k statistic was used to assess interobserver variability. The guidelines of Landis and Koch were followed in interpreting k values: 0.00Á0.20, slight agreement; 0.21Á0.40, fair agreement; 0.41Á0.60, moderate agreement; 0.61Á0.80, substantial agreement; and 0.80Á1.00, almost perfect agreement (17) . All k statistics were calculated with statistical software (Stata, version 8; Stata, College Station, Tex., USA). Among the 61 diffuse astrocytomas, the final pathologic diagnosis was 26 low-grade astrocytomas, 12 anaplastic astrocytomas, and 23 glioblastoma multiforme. PASL imagings showed heterogeneous blood flow distribution within an individual tumor (Fig. 2) . The sensitivity, specificity, PPV, and NPV for determining a high-grade glioma with conventional MR imaging were 77.1, 73.1, 79.4, and 70.4%, respectively. In the ROC curve analyses, the area under the curve (AUC) for rTPS was significantly larger than that of conventional imaging (0.955 vs. 0.751, P 00.002) (Fig. 3) . A threshold value of 1.28 for rTPS provided sensitivity, specificity, PPV, and NPV of 82.9, 96.2, 96.7, and 80.6%, respectively (Fig. 4) . Tables 1 and 2 show the sensitivity, specificity, PPV, and NPV for determining a high-grade glioma using the rTPS of PASL according to the threshold values and for each observer. There was a statistically significant difference in the rTPS between low-and high-grade astrocytomas (1.14 vs. 1.47, P B0.05). No statistically significant difference was noted in the rTPS between the anaplastic astrocytoma and glioblastoma multiforme groups (1.41 vs. 1.52, P0.05). The correlation between the tumor grade and rTPS values was statistically significant (Spearman's rho 0.84, P 00.001) (Fig. 5) . For the interobserver variability analysis between the two observers, substantial agreement was obtained for quantitative rTPS measurement on PASL (k00.72).
Results
In
Discussion
Our results demonstrated a close correlation between the maximum tumor perfusion signal intensity of PASL and the grading of gliomas. PASL gave significantly higher rTPS values in patients with high-grade gliomas than in those with lowgrade gliomas and was able to show heterogeneous blood flow distribution within an individual tumor. However, the interobserver variability in the rTPS quantification was substantial.
Perfusion imaging in brain tumors has important clinical and diagnostic implications. We were able to show that PASL allowed reliable differentiation between low-grade and high-grade gliomas, as has been shown by other investigators with different perfusion imaging techniques (18, 19) . The current practice of contrast-enhanced MR imaging for brain tumors is based on the permeability of contrast agents through the disrupted bloodÁbrain barrier and does not provide specific information about tumor angiogenesis. Conventional MR imaging allows assessment of glioma morphology, and the administration of gadolinium-based contrast media enables specific identification of areas with a disrupted bloodÁbrain barrier. In general, the extent of bloodÁbrain barrier disruption in gliomas increases with malignancy. However, as shown by our study, high-grade gliomas may not show contrast enhancement (20, 21) .
Recent advances in dynamic MR imaging have facilitated quantitative assessment of tumor microcirculation. DSC perfusion MR imaging yields information regarding CBV, CBF, and mean transit time (MTT) from the time course of signal intensity change after contrast injection. Use Fig. 3 . Comparison of receiver operating characteristic curve for determining high-and low-grade gliomas between conventional imaging and relative tumor perfusion signal intensity (rTPS) of pulsed arterial spin labeling (PASL). Fig. 4 . Interactive dot diagram. The sensitivity and specificity for determining high-and low-grade gliomas with the relative tumor perfusion signal intensity (rTPS) were 82.9% and 96.2%, respectively, with a threshold value of 1.28. Table 1 . The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for determining a high-grade glioma using relative tumor perfusion signal intensity of pulsed arterial spin labeling according to the threshold values.
Threshold
Sensitivity Specificity PPV NPV of an appropriate input function also allows for absolute quantification based on the adequate tracer kinetic model (22, 23) . As a result, DSC perfusion imaging has been used in the characterization of tumors (18) . The DSC perfusion MR image is superior in that it yields perfusion maps with a far better signal-to-noise ratio and allows acquisition of a larger number of sections. With ASL, CBF can be quantified using the general kinetic model, an adaptation of the Kety model of ASL described by BUXTON et al. (24) . Previous studies suggest that characterization of cerebral perfusion by FAIR and DSC MR perfusion imaging were comparable in normal patients and in patients with stroke (25, 26) . ASL has the advantage of being noninvasive and does not require administration of an extrinsic tracer. Contrast-enhanced perfusion imaging can be affected by changes in the bloodÁbrain barrier and tumor permeability (27) , but similar effects on PASL have not yet been evaluated. A perfusionweighted difference image of PASL is available immediately after acquisition with only minimal postprocessing. The FAIR image used in our study can be obtained by a simple subtraction and does not require additional workstation or PC-based postprocessing. In our study, the time of acquisition and postprocessing for PASL was comparable to that for DSC MR perfusion imaging. PASL perfusion data can be obtained in a flexible manner with possible repeated acquisition and can be integrated into a conventional MR examination at any time as long as no contrast agent has been administered (18) .
In the radiologic evaluation of brain tumors, techniques for measuring tumor perfusion using PASL should have the following conditions. First, the technique should enable the reliable identification of the areas containing the highest tumor perfusion, because it has been previously shown that the magnitude of the tumor perfusion value correlates with the degree of neovascularization (12) . Second, measurements should be reproducible and the level of interobserver error should be known so that results can be interpreted critically. Finally, the technique should be time efficient. Tumor perfusion measurements obtained with PASL perfusion MR imaging are subject to random errors. Random errors due to noise in the data and tissue variability pose a difficult problem. PASL imaging generally shows lower signal-to-noise ratio than DSC perfusion imaging. Therefore, the reproducibility and interobserver variability of the results of PASL MR imaging must be established in a more clinically realistic setting before the technique can find more widespread use. In our study, the diagnostic accuracy of adjunctive PASL in combination with anatomic imaging for determining highand low-grade gliomas was significantly higher than that of anatomical MR imaging alone, despite the substantial interobserver variability.
Our study has some limitations. The stereotactic biopsy has limitations such as inherent sampling error associated with the limited number of biopsy samples. As shown by a previous report, tumors classified by stereotactic biopsy as being of low or intermediate grade were found to be malignant by open surgical resection in 63% of cases; anaplastic astrocytomas were upgraded to glioblastoma multiforme in 60% of cases (28) . In this study, stereotactic biopsy was performed in nine patients with glioblastoma multiforme, whose clinical situation made craniotomy and resection less desirable. We Table 2 . The optimal threshold value, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of receiver operating characteristic curve analysis for determining a high-grade glioma using relative tumor perfusion signal intensity from each observer and averaged relative tumor perfusion signal intensity between the two observers. excluded grade II and grade III gliomas proven by stereotactic biopsies in this study, and all stereotactic samples were reviewed by an experienced neuropathologist. The weighting of the perfusion image obtained with ASL depends on the timing of the sequence. In older patients, in whom lower perfusion leads to longer transit times, the distal end of the labeled bolus does not reach the capillary bed, and part of the blood is still contained in the arterial vessels. With a change in the timing parameters of the ASL sequence, the examiner can choose the vascular level at which imaging takes place, that is, whether arterial or capillary blood predominates. However, this limits the applicability of the theoretical model of quantification; a model that is based on the assumption that all labeled blood is within its target voxel at the time of acquisition. A second potential limitation of our study is the semiquantification of the rTPS using an internal reference method within the same voxel. The effects of tumor heterogeneity and regional differences in tumor perfusion are difficult to assess. Definition of the tumor ROI could have been biased by knowledge of the tumor type and grade in case of weak or absent enhancement. We made quantitative analysis of PASL 4 weeks after reviewing conventional images in order to prevent recall bias.
In conclusion, the potential to achieve repeated image acquisition and easy integration into a conventional MR examination at any time as long as no contrast agent has been administered are clear advantages of PASL. The interobserver variability for quantifying tumor perfusion using PASL is substantial, and a standardized quantification method should be developed. Nevertheless, for each investigator in our study, adjunctive PASL in combination with anatomic images improved the diagnostic accuracy of preoperative glioma grading, as compared to the application of anatomical imaging alone.
